Clinical Trials Directory

Trials / Completed

CompletedNCT01635010

Obstructive Sleep Apnea in the Absence of Metabolic Syndrome

Obstructive Sleep Apnea in the Absence of Metabolic Syndrome: Pulse Wave Velocity, Inflammatory and Oxidative Stress Markers

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Associação Fundo de Incentivo à Pesquisa · Academic / Other
Sex
Male
Age
25 Years – 60 Years
Healthy volunteers
Accepted

Summary

Obstructive Sleep Apnea (OSA) is commonly associated with factors that increase cardiovascular risk, including Metabolic Syndrome (MS). There is a lack of well-controlled clinical studies investigating the independent effects of OSA in the development of cardiovascular disease, especially evaluating jointly mechanisms involved in these disorders such as inflammatory response, oxidative stress and vascular changes. The investigators hypothesized that in the absence of MetS, the mechanisms involved on cardiovascular consequences in OSA patients would be less important. The purpose of this study is to analyze the effects of OSA in the absence of MS, on inflammatory, oxidative stress and vascular markers; to verify the influence of excessive daytime sleepiness (EDS) on the same parameters; and additionally verify the effects of nasal continuous positive airway pressure (nCPAP)in theses parameters.

Conditions

Interventions

TypeNameDescription
PROCEDUREcontinuous positive airway pressure (CPAP)CPAP pressure is individually prescript according to polysomnography for CPAP titration

Timeline

Start date
2008-12-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2012-07-06
Last updated
2012-07-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01635010. Inclusion in this directory is not an endorsement.